These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18094029

  • 21. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA, Podracka L, Boor A, Jurkovic I, Mitro A, Kovacs L.
    Bratisl Lek Listy; 1999 Sep; 100(9):476-80. PubMed ID: 10645036
    [Abstract] [Full Text] [Related]

  • 22. Effects of eplerenone on heart and kidney in two-kidney, one-clip rats.
    Hao L, Kanno Y, Fukushima R, Watanabe Y, Ishida Y, Suzuki H.
    Am J Nephrol; 2004 Sep; 24(1):54-60. PubMed ID: 14707436
    [Abstract] [Full Text] [Related]

  • 23. Renoprotective effects of mineralocorticoid receptor blockade in heminephrectomized (pro)renin receptor transgenic rats.
    Mizuguchi Y, Ichihara A, Seki Y, Sakoda M, Kurauchi-Mito A, Narita T, Kinouchi K, Bokuda K, Itoh H.
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):569-73. PubMed ID: 20082625
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
    Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS, Roniker B, Patrick JL, Krause SL.
    Am J Cardiol; 2004 Apr 15; 93(8):990-6. PubMed ID: 15081441
    [Abstract] [Full Text] [Related]

  • 25. Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome.
    Ramadan R, Faour D, Awad H, Khateeb E, Cohen R, Yahia A, Torgovicky R, Cohen R, Lazari D, Kawachi H, Abassi Z.
    Nephrol Dial Transplant; 2012 Jun 15; 27(6):2231-41. PubMed ID: 22036940
    [Abstract] [Full Text] [Related]

  • 26. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 27. Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension.
    Suzuki J, Otsuka F, Inagaki K, Tanabe K, Tsukamoto N, Miyoshi T, Nakamura E, Ogura T, Kumagai I, Makino H.
    Hypertens Res; 2011 Mar 15; 34(3):404-6. PubMed ID: 21160478
    [No Abstract] [Full Text] [Related]

  • 28. Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.
    Boesby L, Elung-Jensen T, Klausen TW, Strandgaard S, Kamper AL.
    PLoS One; 2011 Mar 15; 6(11):e26904. PubMed ID: 22073219
    [Abstract] [Full Text] [Related]

  • 29. The effect of enalapril on nephrotic proteinuria and determination of serum angiotensin-converting enzyme before and after treatment.
    Bianchini G, Letizia C, Domenici A, Scavo D.
    Drugs Exp Clin Res; 1991 Mar 15; 17(5):263-9. PubMed ID: 1661665
    [Abstract] [Full Text] [Related]

  • 30. Combined effects of enalapril and spironolactone in hamsters with dilated cardiomyopathy.
    Goineau S, Pape D, Guillo P, Ramée MP, Bellissant E.
    J Cardiovasc Pharmacol; 2003 Jan 15; 41(1):49-59. PubMed ID: 12500021
    [Abstract] [Full Text] [Related]

  • 31. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B, Vajo Z, Dachman W.
    Acta Physiol Hung; 1996 Jan 15; 84(4):361-7. PubMed ID: 9328608
    [Abstract] [Full Text] [Related]

  • 32. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr 15; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 33. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S.
    Hypertens Res; 2011 Jul 15; 34(7):817-24. PubMed ID: 21471977
    [Abstract] [Full Text] [Related]

  • 34. In vivo visualization of the antialbuminuric effects of the angiotensin-converting enzyme inhibitor enalapril.
    Schießl IM, Kattler V, Castrop H.
    J Pharmacol Exp Ther; 2015 May 15; 353(2):299-306. PubMed ID: 25680709
    [Abstract] [Full Text] [Related]

  • 35. Aldosterone antagonism and myocardial infarction: from animals to man and back.
    Solomon SD, Pfeffer MA.
    J Am Coll Cardiol; 2003 Nov 05; 42(9):1674-6. PubMed ID: 14607458
    [No Abstract] [Full Text] [Related]

  • 36. [The additive antiproteinuric effect of Enalapril and Losartan to normotensive patients with pathology proteinuria].
    Liern M, Dieguez SM, De Reyes V, Vallejos G, Canepa C.
    Nefrologia; 2004 Nov 05; 24(6):553-8. PubMed ID: 15683027
    [Abstract] [Full Text] [Related]

  • 37. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K, Nishiyama C, Arisaka N, Takahashi T, Souma S, Tsuda M, Hayashi M, Kasahara H, Kodama H, Tamura T, Murakami M, Kuroda J, Sato F.
    Arzneimittelforschung; 2009 Nov 05; 59(2):79-85. PubMed ID: 19338138
    [Abstract] [Full Text] [Related]

  • 38. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994 Nov 05; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 39. Enalapril dosage in steroid-resistant nephrotic syndrome.
    Bagga A, Mudigoudar BD, Hari P, Vasudev V.
    Pediatr Nephrol; 2004 Jan 05; 19(1):45-50. PubMed ID: 14648339
    [Abstract] [Full Text] [Related]

  • 40. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
    Sato A, Hayashi K, Saruta T.
    Am J Hypertens; 2005 Jan 05; 18(1):44-9. PubMed ID: 15691616
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.